Net Cash Provided by (Used in) Financing Activities in USD of BIOGEN INC. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOGEN INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2010 to Q1 2025.
  • BIOGEN INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$23M, a 94.8% increase year-over-year.
  • BIOGEN INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$684M, a 558% decline from 2023.
  • BIOGEN INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $149M.
  • BIOGEN INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.75B, a 16.2% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOGEN INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$23M +$417M +94.8% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q1 2024 -$440M -$396M -913% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q1 2023 -$43.4M -$26.9M -163% 01 Jan 2023 31 Mar 2023 10-Q 24 Apr 2024
Q1 2022 -$16.5M +$769M +97.9% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023
Q1 2021 -$785M +$1.46B +65% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q1 2020 -$2.25B -$1.57B -231% 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021
Q1 2019 -$679M -$411M -153% 01 Jan 2019 31 Mar 2019 10-Q 23 Apr 2020
Q1 2018 -$269M +$633M +70.2% 01 Jan 2018 31 Mar 2018 10-Q 24 Apr 2019
Q1 2017 -$901M -$896M -17928% 01 Jan 2017 31 Mar 2017 10-Q 24 Apr 2018
Q1 2016 -$5M -$85.8M -106% 01 Jan 2016 31 Mar 2016 10-Q 25 Apr 2017
Q1 2015 $80.8M -$34.1M -29.7% 01 Jan 2015 31 Mar 2015 10-Q 21 Apr 2016
Q1 2014 $115M +$353M 01 Jan 2014 31 Mar 2014 10-Q 24 Apr 2015
Q1 2013 -$238M +$178M +42.7% 01 Jan 2013 31 Mar 2013 10-Q 23 Apr 2014
Q1 2012 -$416M -$316M -317% 01 Jan 2012 31 Mar 2012 10-Q 25 Apr 2013
Q1 2011 -$99.8M +$424M +80.9% 01 Jan 2011 31 Mar 2011 10-Q 01 May 2012
Q1 2010 -$523M 01 Jan 2010 31 Mar 2010 10-Q 21 Apr 2011

BIOGEN INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$684M -$833M -558% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2025
2023 $149M +$1.9B 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2025
2022 -$1.75B +$339M +16.2% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025
2021 -$2.09B +$3.19B +60.4% 01 Jan 2021 31 Dec 2021 10-K 14 Feb 2024
2020 -$5.27B +$588M +10% 01 Jan 2020 31 Dec 2020 10-K 15 Feb 2023
2019 -$5.86B -$1.39B -31% 01 Jan 2019 31 Dec 2019 10-K 03 Feb 2022
2018 -$4.47B -$2.09B -87.9% 01 Jan 2018 31 Dec 2018 10-K 03 Feb 2021
2017 -$2.38B -$1.33B -126% 01 Jan 2017 31 Dec 2017 10-K 06 Feb 2020
2016 -$1.05B -$1.84B -234% 01 Jan 2016 31 Dec 2016 10-K 06 Feb 2019
2015 $783M +$1.54B 01 Jan 2015 31 Dec 2015 10-K 01 Feb 2018
2014 -$756M -$39.4M -5.5% 01 Jan 2014 31 Dec 2014 10-K 02 Feb 2017
2013 -$717M +$161M +18.3% 01 Jan 2013 31 Dec 2013 10-K 03 Feb 2016
2012 -$877M -$558M -174% 01 Jan 2012 31 Dec 2012 10-K 04 Feb 2015
2011 -$320M +$1.47B +82.1% 01 Jan 2011 31 Dec 2011 10-K 06 Feb 2014
2010 -$1.78B 01 Jan 2010 31 Dec 2010 10-K 05 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.